These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1645 related articles for article (PubMed ID: 19454804)

  • 21. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
    Harrison JD; Muirhead CR
    Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
    Richardson DB
    Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M; Luebeck EG; Moolgavkar SH
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
    Ron E; Lubin JH; Shore RE; Mabuchi K; Modan B; Pottern LM; Schneider AB; Tucker MA; Boice JD
    Radiat Res; 1995 Mar; 141(3):259-77. PubMed ID: 7871153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ; Hoel DG
    Radiat Res; 1992 May; 130(2):249-66. PubMed ID: 1574582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation and cancer risk in atomic-bomb survivors.
    Kodama K; Ozasa K; Okubo T
    J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of time and age patterns in cancer risk for A-bomb survivors.
    Pierce DA; Vaeth M; Preston DL
    Radiat Res; 1991 May; 126(2):171-86. PubMed ID: 2023988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid cancer mortality associated with chronic external radiation exposure at the French atomic energy commission and nuclear fuel company.
    Metz-Flamant C; Samson E; Caër-Lorho S; Acker A; Laurier D
    Radiat Res; 2011 Jul; 176(1):115-27. PubMed ID: 21476856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 83.